On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are ORCA Therapeutics BV's own share of each project, not the project's full budget.
- Horizon 2020€255k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- VIRIONPartner
Viruses, Immune stimulation and RNA Interference in Oncology Network
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€255ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Stichting VuNetherlands · 1 shared project
- Stichting Amsterdam UmcNetherlands · 1 shared project
- Tilt Biotherapeutics OyFinland · 1 shared project
- Quintess Consultancy BVNetherlands · 1 shared project
- Diamond Biopharm LimitedUnited Kingdom · 1 shared project
- Hyphen Projects BVNetherlands · 1 shared project
- AdiuTide Pharmaceuticals GmbHGermany · 1 shared project
- Netherlands society of gene and cell therapyNetherlands · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- cells technologies
- immunotherapy
- melanoma
- surgery
- virology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.